Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
97.41%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 3.04Close
$ 0.42 - $ 4.74 52-Week Range
Ticker Information
Ticker
ABVCCompany Name
ABVC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQABVC BIOPHARMA INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABVC - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 381.11K | 97.41% | $ 391.24K |
| 3/31/2025 | $ 313.58K | 61.68% | $ 508.38K |
| 12/31/2024 | $ 200.92K | 39.43% | $ 509.59K |
| 9/30/2024 | $ 29.19K | 5.73% | $ 509.79K |
| 6/30/2024 | $ 29.63K | 21.72% | $ 136.4K |
| 3/31/2024 | $ 23.32K | 91.96% | $ 25.36K |
| 12/31/2023 | $ 28.53K | 18.72% | $ 152.43K |
| 9/30/2023 | $ 27.38K | 3.7% | $ 739.26K |
| 6/30/2023 | $ 26.39K | 3.45% | $ 765.64K |
| 3/31/2023 | $ 24.88K | 2.32% | $ 1.07M |
Key Performance Insights, Last 5 Years
- ABVC BIOPHARMA INC's latest trailing twelve months (TTM) DepAmor % stands at 3.37%.
- Over the past 5 years, ABVC BIOPHARMA INC's average DepAmor % has been 24.96%.
- The median DepAmor % for ABVC BIOPHARMA INC during this period was 6.02%
- ABVC BIOPHARMA INC reached its highest DepAmor % over the past 5 years at 97.41%.
- The lowest DepAmor % recorded by ABVC BIOPHARMA INC in the same timeframe 2.32%
ABVC BIOPHARMA INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ABVC BIOPHARMA INC is calculated as follows: DepAmor [ $ 11.99K ] / Revenues [ $ 355.8K ]
(=) DepAmor % [ 3.37% ] ABVC - Depreciation and Amortization Margin, Last 5 years
2.32%
Minimum
Mar 31, 2023
97.41%
Maximum
Jun 30, 2025
24.96%
Average
6.02%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |